149 related articles for article (PubMed ID: 8952864)
1. Resistance to activated protein C: role in venous and arterial thrombosis.
Emmerich J; Alhenc-Gelas M; Aiach M; Fiessinger JN
Biomed Pharmacother; 1996; 50(6-7):254-60. PubMed ID: 8952864
[TBL] [Abstract][Full Text] [Related]
2. [Activated protein C resistance: role in venous and arterial thrombosis].
Emmerich J; Alhenc-Gelas M; Aiach M; Fiessinger JN
Arch Mal Coeur Vaiss; 1996 Jun; 89(6):741-5. PubMed ID: 8760661
[TBL] [Abstract][Full Text] [Related]
3. Resistance to activated protein C: a major cause of inherited thrombophilia.
Jensen R; Ens GE
Clin Lab Sci; 1997; 10(4):219-22. PubMed ID: 10169621
[TBL] [Abstract][Full Text] [Related]
4. Activated protein C resistance--a major risk factor for thrombosis.
Rosén SB; Sturk A
Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):501-16. PubMed ID: 9263726
[TBL] [Abstract][Full Text] [Related]
5. [Resistance to activated protein C disclosed by postphlebitic disease. Two cases].
Foueré S; Lestang P; Cosnes A; Gouault-Heilmann M; Revuz J
Ann Dermatol Venereol; 1996; 123(1):24-5. PubMed ID: 8734112
[TBL] [Abstract][Full Text] [Related]
6. Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C.
Zöller B; Svensson PJ; He X; Dahlbäck B
J Clin Invest; 1994 Dec; 94(6):2521-4. PubMed ID: 7989612
[TBL] [Abstract][Full Text] [Related]
7. [Resistance to activated protein C--a novel cause of thrombophilia].
Cycowitz Z; Seligsohn U; Zivelin A; Eldor A
Harefuah; 1995 Jul; 129(1-2):1-5, 80. PubMed ID: 7557699
[TBL] [Abstract][Full Text] [Related]
8. Resistance to activated protein C caused by the R506Q mutation in the gene for factor V is a common risk factor for venous thrombosis.
Dahlbck B
J Intern Med Suppl; 1997; 740():1-8. PubMed ID: 9350175
[TBL] [Abstract][Full Text] [Related]
9. [Activated protein C resistance in Behçet disease].
Guermazi S; M'Rad S; Lamloum M; Houman MH; Hamza M; Ben Dridi M; Miled M; Dellagi K
Pathol Biol (Paris); 1998 Dec; 46(10):791-5. PubMed ID: 9922996
[TBL] [Abstract][Full Text] [Related]
10. Resistance to activated protein C caused by the factor VR506Q mutation is a common risk factor for venous thrombosis.
Dahlbäck B
Thromb Haemost; 1997 Jul; 78(1):483-8. PubMed ID: 9198201
[TBL] [Abstract][Full Text] [Related]
11. [Activated protein C resistance--a recently discovered hereditary thrombophilia].
Moland L; Sandset PM
Tidsskr Nor Laegeforen; 1998 Sep; 118(23):3590-5. PubMed ID: 9820002
[TBL] [Abstract][Full Text] [Related]
12. Resistance to activated protein C as risk factor for thrombosis: molecular mechanisms, laboratory investigation, and clinical management.
Dahlbäck B
Semin Hematol; 1997 Jul; 34(3):217-34. PubMed ID: 9241707
[TBL] [Abstract][Full Text] [Related]
13. [A new cause of hereditary venous thrombosis: activated protein C resistance].
Trossaërt M; Conard J; Horellou MH; Meyer Samama M
Ann Cardiol Angeiol (Paris); 1995 Oct; 44(8):438-42. PubMed ID: 8669795
[No Abstract] [Full Text] [Related]
14. Are patients with thrombophilia and previous venous thromboembolism at higher risk to arterial thrombosis?
Linnemann B; Schindewolf M; Zgouras D; Erbe M; Jarosch-Preusche M; Lindhoff-Last E
Thromb Res; 2008; 121(6):743-50. PubMed ID: 17804043
[TBL] [Abstract][Full Text] [Related]
15. [Resistance to activated protein C. The most common cause of familial thrombophilia].
Larsen TB; Ravn HB; Lassen JF; Lund ED; Brandslund I
Ugeskr Laeger; 1996 Nov; 158(46):6584-8. PubMed ID: 8966822
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of original and modified APC-resistance tests in unselected outpatients with clinically suspected thrombosis and in healthy controls.
Svensson PJ; Zöller B; Dahlbäck B
Thromb Haemost; 1997 Feb; 77(2):332-5. PubMed ID: 9157592
[TBL] [Abstract][Full Text] [Related]
17. The mutation Ala677-->Val in the methylene tetrahydrofolate reductase gene: a risk factor for arterial disease and venous thrombosis.
Arruda VR; von Zuben PM; Chiaparini LC; Annichino-Bizzacchi JM; Costa FF
Thromb Haemost; 1997 May; 77(5):818-21. PubMed ID: 9184384
[TBL] [Abstract][Full Text] [Related]
18. Incidence and clinical manifestations of activated protein C resistance and factor V Leiden in young patients with venous thromboembolic disease in Spain.
Olave T; Cornudella R; Homs C; Azaceta G; Tirado I; Gutierrez M
Haematologica; 1998 Apr; 83(4):378-80. PubMed ID: 9592991
[TBL] [Abstract][Full Text] [Related]
19. Resistance to activated protein C due to factor V R506Q mutation as a cause of venous thrombosis.
Dahlbäck B
Rev Invest Clin; 1997 May; 49 Suppl 1():3-5. PubMed ID: 9291738
[No Abstract] [Full Text] [Related]
20. Prevalence of factor V Leiden mutation and other hereditary thrombophilic factors in Egyptian children with portal vein thrombosis: results of a single-center case-control study.
El-Karaksy H; El-Koofy N; El-Hawary M; Mostafa A; Aziz M; El-Shabrawi M; Mohsen NA; Kotb M; El-Raziky M; El-Sonoon MA; A-Kader H
Ann Hematol; 2004 Nov; 83(11):712-5. PubMed ID: 15309526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
